Evidence map›Paper›PMID 38440241›Full record

ArticleFrontiers in psychology2024

The efficacy of augmented reality exposure therapy in the treatment of spider phobia-a randomized controlled trial.

Tomas Jurcik, Svetlana Zaremba-Pike, Vladimir Kosonogov, Abdul-Raheem Mohammed, Yulia Krasavtseva, Tadamasa Sawada, Irina Samarina, Nilufar Buranova, Peter Adu, Nikita Sergeev and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Tomas JurcikSchool of Psychology, HSE University, Moscow, Russia.
Svetlana Zaremba-PikeSchool of Psychology, HSE University, Moscow, Russia.
Vladimir KosonogovHSE University, Moscow, Russia.
Abdul-Raheem MohammedDepartment of Social and Behavioral Change, School of Public Health, University for Development Studies, Tamale, Ghana.
Yulia KrasavtsevaDepartment of Pedagogy and Medical Psychology, Sechenov University, Moscow, Russia.
Tadamasa SawadaSchool of Psychology, HSE University, Moscow, Russia.
Irina SamarinaDepartment of Healthcare, P. B. Gannushkin Moscow Clinical Psychiatric Hospital No. 4, Moscow, Russia.
Nilufar BuranovaCenter for Cognitive Therapy, Moscow, Russia.
Peter AduWellington Faculty of Health, Victoria University of Wellington, Wellington, New Zealand.
Nikita SergeevDepartment of Computer Engineering, HSE University, Moscow, Russia.
Andrei SkuratovDepartment of Computer Engineering, HSE University, Moscow, Russia.
Anastasia DemchenkoCenter for Cognitive Therapy, Moscow, Russia.
Yakov KochetkovCenter for Cognitive Therapy, Moscow, Russia.
National Research University Higher School of Economics · RULomonosov Moscow State University · RUUniversity for Development Studies · GHVictoria University of Wellington · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evidence for the use of Augmented Reality (AR) in treating specific phobias has been growing. However, issues of accessibility persist, especially in developing countries. The current study examined a novel, but relatively simple therapist guided smartphone-based AR Exposure Treatment (ARET) of spider phobia. Participants who reported symptoms of Arachnophobia were randomized into one of three comparison groups: ARET (

Indexed as

augmented realityexposure therapyin-vivophobiaspider

Identifiers

PMID38440241
PMCPMC10911123
OpenAlexW4391932955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.